These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation. Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244 [TBL] [Abstract][Full Text] [Related]
6. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients. Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316 [TBL] [Abstract][Full Text] [Related]
7. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience. Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087 [TBL] [Abstract][Full Text] [Related]
8. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT). DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620 [TBL] [Abstract][Full Text] [Related]
9. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators. Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940 [TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912 [TBL] [Abstract][Full Text] [Related]
12. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study. Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J Transplantation; 2024 Sep; 108(9):1931-1942. PubMed ID: 38538559 [TBL] [Abstract][Full Text] [Related]
13. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients. Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125 [TBL] [Abstract][Full Text] [Related]
14. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation. Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559 [TBL] [Abstract][Full Text] [Related]
15. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA; Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637 [TBL] [Abstract][Full Text] [Related]
16. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation. Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524 [TBL] [Abstract][Full Text] [Related]
17. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531 [TBL] [Abstract][Full Text] [Related]
18. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731 [TBL] [Abstract][Full Text] [Related]
19. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant. Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112 [TBL] [Abstract][Full Text] [Related]
20. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant. Rosenheck JP; Ross DJ; Botros M; Wong A; Sternberg J; Chen YA; Liang N; Baer A; Ahmed E; Swenerton R; Zimmermann BG; Fehringer G; Demko ZP; Olymbios M; Billings PR; Keller BC Transplant Direct; 2022 Apr; 8(4):e1317. PubMed ID: 35372675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]